Detalles de la búsqueda
1.
Patient-reported distress in Hodgkin lymphoma across the survivorship continuum.
Support Care Cancer
; 27(7): 2453-2462, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30377801
2.
Real-World Economic Burden Associated with Transplantation-Related Complications.
Biol Blood Marrow Transplant
; 23(10): 1788-1794, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28688917
3.
Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma.
Br J Haematol
; 175(5): 860-867, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27649689
4.
Use of intravenous bisphosphonates in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems.
Support Care Cancer
; 22(5): 1363-73, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24389827
5.
Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems.
Support Care Cancer
; 21(12): 3279-86, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23884473
6.
Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study.
Eur J Cancer
; 133: 120-130, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32502876
7.
Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage III or IV classical Hodgkin lymphoma.
J Med Econ
; 22(2): 117-130, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30375910
8.
Real-world analysis of cost, health care resource utilization, and supportive care in Hodgkin lymphoma patients with frontline failure.
Clinicoecon Outcomes Res
; 10: 629-641, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30410373
9.
Brentuximab vedotin consolidation post-autologous stem cell transplant in Hodgkin lymphoma patients at risk of residual disease: number needed to treat.
Leuk Lymphoma
; 59(1): 69-76, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28583027
10.
Real-world economic burden of hematopoietic cell transplantation among a large US commercially insured population with hematologic malignancies.
J Med Econ
; 20(12): 1244-1251, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28782449
11.
Lipid-lowering treatment modifications among patients with hyperlipidemia and a prior cardiovascular event: a US retrospective cohort study.
Curr Med Res Opin
; 33(5): 869-876, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28276256
12.
Patient-level costs of major cardiovascular conditions: a review of the international literature.
Clinicoecon Outcomes Res
; 8: 495-506, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27703385
13.
Systematic Review of Low-Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia.
J Am Heart Assoc
; 5(7)2016 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27385428
14.
Medical costs associated with cardiovascular events among high-risk patients with hyperlipidemia.
Clinicoecon Outcomes Res
; 7: 337-45, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26089693
15.
Burden of First and Recurrent Cardiovascular Events Among Patients With Hyperlipidemia.
Clin Cardiol
; 38(8): 483-91, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26100722
16.
Time associated with intravenous zoledronic acid administration in patients with breast or prostate cancer and bone metastasis.
Cancer Manag Res
; 4: 55-60, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22427731
17.
Treatment patterns in patients with prostate cancer and bone metastasis among US community-based urology group practices.
Urology
; 80(2): 293-8, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22748612
Resultados
1 -
17
de 17
1
Próxima >
>>